Effect of vitamin D supplementation on the functional efficiency of patients after stroke
Not Applicable
- Conditions
- Patients who had their first ischemic stroke were admitted to the ward for early post-stroke rehabilitationCirculatory SystemStroke, not specified as haemorrhage or infarction
- Registration Number
- ISRCTN11086312
- Lead Sponsor
- Wroclaw Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. First ischemic stroke (time of occurrence 2 weeks before admission to the Department of Neurological Rehabilitation)
2. Stroke confirmed by MR or CT scan
3. Age >18 years old
4. No contraindications to participate in the experiment (consent of the attending physician)
5. No concomitant neurological diseases
6. Written informed consent of the patient to participate in the research
Exclusion Criteria
1. Patients with infection in the last 2 weeks
2. Patients who have taken vitamin D and its derivatives or calcium in the last 3 months
3. Patients with liver and kidney disorders
4. Patients with thyroid dysfunction
5. Patients with aphasia
6. Patients who do not consent to the research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Clinical symptoms in the course of stroke were assessed using the National Institute of Health Stroke Scale (NIHSS) at baseline and after the intervention and 1 and 3 months after the intervention<br> 2. Everyday activity assessed using the Barthel Scale at baseline and after the intervention and 1 and 3 months after the intervention<br> 3. Degree of disability assessed using the Modified Rankin Scale at baseline and after the intervention and 1 and 3 months after the intervention<br>
- Secondary Outcome Measures
Name Time Method Complete blood count, urine analysis, and concentration of 25(OH)D and IGF-1 measured using basic laboratory tests before and after the intervention at baseline and after the intervention and 1 and 3 months after the intervention